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. 1 H NMR spectrum of 13 2 -hydroxy-pheophytin a, compound 1, in DMSO-d6 (400 MHz). Figure S2 . 13 C NMR spectrum of 13 2 -hydroxy-pheophytin a, compound 1, in DMSO-d6 (400 MHz). Figure S3 . HSQC spectrum of 13 2 -hydroxy-pheophytin a, compound 1, in DMSO-d6 (400 MHz). Figure S4 . HMBC spectrum of 13 2 -hydroxy-pheophytin a, compound 1, in DMSO-d6 (400 MHz). Figure S8 . 1 H NMR spectrum of 13 2 -hydroxy-pheofarnesin a, compound 2, in CDCl3 (600 MHz). Figure S9 . 13 C NMR spectrum of 13 2 -hydroxy-pheofarnesin a, compound 2, in CDCl3 (600 MHz). Figure S10 . HSQC spectrum of 13 2 -hydroxy-pheofarnesin a, compound 2, in CDCl3 (600 MHz). Figure S11 . HMBC spectrum of 13 2 -hydroxy-pheofarnesin a, compound 2, in CDCl3 (600 MHz). Figure S16. 3T3-L1 organoids without differentiation induction (upper images) and after differentiation induction (lower images). Differentiated organoids were formed during 5 days in DMEM medium and then exposed for 3 days to a differentiated medium, containing 10 µg/ml of insulin, 250 nM dexamethasone and 500 µM of isobutylmethylxanthine. After this step, an exposure assay to 1 or 2 can take place. Not differentiation organoids were cultured as differentiated organoids but without the differentiation medium. Figure S 16 -3T3-L1 organoids without differentiation induction (upper images) and after differentiation induction (lower images). Differentiated organoids were formed during 5 days in DMEM medium and then exposed for 3 days to a differentiated medium, containing 10 µg/ml of insulin, 250 nM dexamethasone and 500 µM of isobutylmethylxanthine. After this step, an exposure assay to 1 or 2 can take place. Not differentiation organoids were cultured as differentiated organoids but without the differentiation medium. 
